Hebibi, H.; Edeas, M.; Cornillac, L.; Beaudreuil, S.; Achiche, J.; Attaf, D.; Saibi, S.; Chazot, C.; Ouaaz, F.; Canaud, B.
SARS-CoV-2 mRNA Vaccine Immunogenicity in Hemodialysis Patients: Promising Vaccine Protection That May Be Hindered by Fluid Overload. Kidney Dial. 2022, 2, 44-56.
https://doi.org/10.3390/kidneydial2010006
AMA Style
Hebibi H, Edeas M, Cornillac L, Beaudreuil S, Achiche J, Attaf D, Saibi S, Chazot C, Ouaaz F, Canaud B.
SARS-CoV-2 mRNA Vaccine Immunogenicity in Hemodialysis Patients: Promising Vaccine Protection That May Be Hindered by Fluid Overload. Kidney and Dialysis. 2022; 2(1):44-56.
https://doi.org/10.3390/kidneydial2010006
Chicago/Turabian Style
Hebibi, Hedia, Marvin Edeas, Laure Cornillac, Severine Beaudreuil, Jedjiga Achiche, David Attaf, Samah Saibi, Charles Chazot, Fatah Ouaaz, and Bernard Canaud.
2022. "SARS-CoV-2 mRNA Vaccine Immunogenicity in Hemodialysis Patients: Promising Vaccine Protection That May Be Hindered by Fluid Overload" Kidney and Dialysis 2, no. 1: 44-56.
https://doi.org/10.3390/kidneydial2010006
APA Style
Hebibi, H., Edeas, M., Cornillac, L., Beaudreuil, S., Achiche, J., Attaf, D., Saibi, S., Chazot, C., Ouaaz, F., & Canaud, B.
(2022). SARS-CoV-2 mRNA Vaccine Immunogenicity in Hemodialysis Patients: Promising Vaccine Protection That May Be Hindered by Fluid Overload. Kidney and Dialysis, 2(1), 44-56.
https://doi.org/10.3390/kidneydial2010006
